MedTrace Logo

Consistently Assess Signs and Symptom of Heart Failure

NCT05833581 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2023-04-27

No results posted yet for this study

Summary

Heart failure (HF) is a major public health problem. The New York Heart Association (NYHA) Functional Classification by a HF provider helps to guide their decisions in patient treatment. The purpose of this study is to further examine the NYHA Classification Guide that is designed to assist healthcare providers. The investigators will conduct the study in the outpatient clinic setting where adult patients with chronic heart failure are treated. HF providers will be asked to complete the NYHA classification Guide and then participants will complete a standardized 6-minute walk test which is considered as the gold standard. Participant results will be compared between providers' assigned class and the results from the 6-minute walk test. The subsequent phase of the study will be incorporation of the NYHA Classification Guide into clinical practice. HF providers will use the NYHA Classification Guide for 30 days in the clinic setting and will report their perceptions.

Conditions

Interventions

OTHER

New York Heart Association Classification Guide

The New York Heart Association Classification Guide is a questionnaire that assists in guiding the provider in selection of the patient's class

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Lancaster General Hospital

    collaborator OTHER

  • University of North Carolina, Greensboro

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Board of Trustees of Illinois State University

    lead OTHER

Principal Investigators

  • Marilyn A. Prasun, PhD · Board of Trustees of Illinois State University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-17
Primary Completion
2023-12-17
Completion
2024-06-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05833581 on ClinicalTrials.gov